Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7444 p337
24 March 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


BNF highly rated as medicines information source

British National Formulary

The BNF's most intensive users are hospital pharmacists

Eight out of 10 health professionals say that the British National Formulary is their favourite source of medicines information.

Research carried out at the end of last year and commissioned by RPS Publishing and the BMJ Publishing Group, which jointly produce the BNF, found that half of doctors, pharmacists and nurses refer to the BNF three times a day or more and that 92 per cent use it several times a week.

The most highly rated attributes of the book were its trustworthiness and authority, with 88 per cent of users believing that it is not influenced by the pharmaceutical industry and 61 per cent believing that it is free of Government influence.

The most intensive users of the BNF were found to be hospital pharmacists, 77 per cent of whom use it three times a day or more. The next heaviest users are primary care nurses (71 per cent using it at least three times a day), community pharmacists (63 per cent) and GPs (62 per cent).

Sir Charles George, director of the BMJ Publishing Group, said: “This independent research reinforces how the BNF is regarded by those with responsibility for prescribing and the importance of its independence from both the pharmaceutical industry and Government.

“Not only do doctors and pharmacists rely on the BNF but nurses, who within a few years may be prescribing more medicines than doctors, also refer to the BNF to ensure consistent standards of prescribing are maintained.”

Martin Kendall, chairman of the joint formulary committee which oversees production of the BNF, said: “This independent research is extremely encouraging since it indicates that the BNF is widely used by all health care professionals because they regard it as trustworthy and authoritative. These results are also encouraging to the editorial team and the advisory boards who work tirelessly to update the information continuously and ensure the high quality and reliability are maintained.”

The research findings were announced as BNF 53 was published.

Latest revisions Revisions in the latest edition of the BNF include a warning that the breast-fed children of mothers who take products containing codeine might be at risk of morphine poisoning if their mothers are extensive metabolisers of codeine.

Guidance on the use of heparin anticoagulants has been updated, as have the recommended regimens for the eradication of Helicobacter pylori in gastric and duodenal ulcer patients and recommendations for preventing and treating malaria. Other revisions are also included.

Back to Top


©The Pharmaceutical Journal